Stocks
Immunome (IMNM) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -6.05 | -0.73 | -1.99 | -2.13 | -8.83 | -10.0 | ||
| Changes by years, y/y, % | +6% | -88% | +174% | +7% | +316% | +9.1% | |||
Immunome. P/E
Immunome. P/E, changes, %
Immunome (IMNM) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | -2.61 | -3.81 | -4.62 | -8.83 | -11.0 | -10.0 | |
| Changes by years, y/y, % | +138% | +38% | +60% | +289% | +323% | |||
| Changes by quarters, q/q, % | +15% | +46% | +21% | +91% | +25% | |||
